Lynx1 Capital Management LP 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:22 am Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Lynx1 Capital Management LP | 3,813,926 6.600% |
687,753 (+22.00%) |
Filing |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Lynx1 Capital Management LP | 3,126,173 6.800% |
1,588,828 (+103.35%) |
Filing |
| 2022-04-22 4:26 pm Purchase |
2022-04-14 | 13G | Alpine Immune Sciences, Inc. ALPN |
Lynx1 Capital Management LP | 1,537,345 5.100% |
1,537,345 (New Position) |
Filing |